Literature DB >> 19833749

Work disability in patients with ankylosing spondylitis.

Rafael Ariza-Ariza1, Blanca Hernández-Cruz, Eduardo Collantes, Enrique Batlle, Jose L Fernández-Sueiro, Jordi Gratacós, Xavier Juanola, Luís F Linares, Juan Mulero, Pedro Zarco.   

Abstract

OBJECTIVE: To determine the prevalence of work disability in Spanish patients with ankylosing spondylitis (AS) and to identify factors related to it.
METHODS: A cross-sectional study based on data from Regisponser (National Spanish Registry of Patients with Spondyloarthropathy). Demographic and disease-related variables were collected. AS patients were classified as work-disabled according to the Spanish Social Security System criteria. Variables that discriminated between AS patients with and those without work disability were identified using chi-square test or unpaired t test when appropriate. Multiple logistic regression was performed.
RESULTS: In total 699 AS patients, age 48.7 +/- SD 12.7 years and with disease duration 14.1 +/- 10.1 years, were analyzed; 179 patients (25.6%) had permanent work disability. Several variables had significantly different values in patients with compared to those without work disability. In the regression model (pseudo R(2) = 0.26, p < 0.0001), age (p = 0.001), sex (p = 0.04), disease duration (p = 0.006), total Bath AS Radiological Index (p = 0.007), Bath AS Functional Index (BASFI; p = 0.007), and chest expansion (p = 0.03) retained an independent association with work disability. When BASFI was excluded from the model the independent association with sex did not remain, and a significant association with finger to floor distance was found (p = 0.040).
CONCLUSION: The prevalence of permanent work disability in Spanish patients with AS is significant, and the main factors related to it are age, disease duration, structural damage, and physical functioning. Longitudinal studies are needed to confirm these results.

Entities:  

Mesh:

Year:  2009        PMID: 19833749     DOI: 10.3899/jrheum.090481

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

Review 1.  Critical Appraisal of the Quality of Literature Evaluating Psychometric Properties of Arthritis Work Outcome Assessments: A Systematic Review.

Authors:  Rawan Alheresh; Molly Vaughan; Michael P LaValley; Wendy Coster; Julie J Keysor
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-07-27       Impact factor: 4.794

2.  Synthetic disease-modifying antirheumatic drug prescribing variability in rheumatoid arthritis: a multilevel analysis of a cross-sectional national study.

Authors:  Iván Ferraz-Amaro; Daniel Seoane-Mato; Fernando Sánchez-Alonso; María A Martín-Martínez
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

3.  Morbidities among older workers and work exit: the HEAF cohort.

Authors:  K Walker-Bone; S D'Angelo; C H Linaker; M J Stevens; G Ntani; C Cooper; H E Syddall
Journal:  Occup Med (Lond)       Date:  2022-10-18       Impact factor: 5.629

4.  Usefulness of a centralized system of data collection for the development of an international multicentre registry of spondyloarthritis.

Authors:  Ruxandra Schiotis; Pilar Font; Alejandro Escudero; Pedro Zarco; Raquel Almodovar; Jordi Gratacós; Juan Mulero; Xavier Juanola; Carlos Montilla; Estefanía Moreno; Rafael Ariza Ariza; Eduardo Collantes-Estevez
Journal:  Rheumatology (Oxford)       Date:  2010-09-07       Impact factor: 7.580

5.  Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.

Authors:  Isidoro González-Álvaro; Carmen Martínez-Fernández; Benito Dorantes-Calderón; Rosario García-Vicuña; Blanca Hernández-Cruz; Alicia Herrero-Ambrosio; Olatz Ibarra-Barrueta; Emilio Martín-Mola; Emilio Monte-Boquet; Alberto Morell-Baladrón; Raimon Sanmartí; Jesús Sanz-Sanz; Francisco Javier de Toro-Santos; Paloma Vela; José Andrés Román Ivorra; José Luis Poveda-Andrés; Santiago Muñoz-Fernández
Journal:  Rheumatology (Oxford)       Date:  2014-12-19       Impact factor: 7.580

Review 6.  Work Disability in Axial Spondyloarthritis.

Authors:  Elena Nikiphorou; Sofia Ramiro
Journal:  Curr Rheumatol Rep       Date:  2020-07-27       Impact factor: 4.592

7.  Outcomes and treatment responses, including work productivity, among people with axial spondyloarthritis living in urban and rural areas: a mixed-methods study within a national register.

Authors:  Rosemary J Hollick; Kevin Stelfox; Linda E Dean; Joanna Shim; Karen Walker-Bone; Gary J Macfarlane
Journal:  Ann Rheum Dis       Date:  2020-06-10       Impact factor: 19.103

8.  Recruitment cost and outcomes for an arthritis work disability prevention randomized clinical trial: The Work It study.

Authors:  Rawan AlHeresh; Molly W Vaughan; Inbar Hanouna Brenner; Julie Keysor
Journal:  Contemp Clin Trials Commun       Date:  2021-11-12

9.  Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitis.

Authors:  Ruxandra Schiotis; Nerea Bartolomé; Alejandra Sánchez; Magdalena Szczypiorska; Jesús Sanz; Eduardo Cuende; Eduardo Collantes Estevez; Antonio Martínez; Diego Tejedor; Marta Artieda; Anca Buzoianu; Juan Mulero
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

10.  Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis.

Authors:  Joanna Shim; Gareth T Jones; Ejaz M I Pathan; Gary J Macfarlane
Journal:  Ann Rheum Dis       Date:  2018-08-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.